Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 33,183 shares at $32.87 ($1.1M) on 2021-05-25, disclosed to the SEC on 2021-05-27.
Open-market sale of $1.1M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.87 | 2,852 | $94K | 8.6% |
| 2 | $32.87 | 2,852 | $94K | 8.6% |
| 3 | $33.59 | 44 | $1K | 0.1% |
| 4 | $32.74 | 9,839 | $322K | 29.6% |
| 5 | $32.74 | 9,839 | $322K | 29.6% |
| 6 | $33.01 | 751 |
| $25K |
| 2.3% |
| 7 | $32.81 | 1,906 | $63K | 5.7% |
| 8 | $32.81 | 1,906 | $63K | 5.7% |
| 9 | $33.16 | 1,597 | $53K | 4.9% |
| 10 | $33.16 | 1,597 | $53K | 4.9% |
| Total | $32.82 avg | 33,183 | $1.1M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |